These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 24906365

  • 1. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
    Lindberg S, Jensen JS, Pedersen SH, Galatius S, Goetze JP, Mogelvang R.
    Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention.
    Bjerre M, Pedersen SH, Møgelvang R, Lindberg S, Jensen JS, Galatius S, Flyvbjerg A.
    Eur J Prev Cardiol; 2013 Dec; 20(6):922-9. PubMed ID: 23613225
    [Abstract] [Full Text] [Related]

  • 4. Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S, Pedersen SH, Mogelvang R, Galatius S, Flyvbjerg A, Jensen JS, Bjerre M.
    Am Heart J; 2012 Nov; 164(5):786-92. PubMed ID: 23137511
    [Abstract] [Full Text] [Related]

  • 5. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
    Niccoli G, Conte M, Marchitti S, Montone RA, Fracassi F, Grippo R, Roberto M, Burzotta F, Trani C, Leone AM, Bianchi F, Di Castro S, Volpe M, Crea F, Rubattu S.
    Cardiovasc Revasc Med; 2016 Nov; 17(3):162-8. PubMed ID: 26987266
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S, Pedersen SH, Mogelvang R, Jensen JS, Flyvbjerg A, Galatius S, Magnusson NE.
    J Am Coll Cardiol; 2012 Jul 24; 60(4):339-45. PubMed ID: 22813613
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
    Baumann S, Huseynov A, Koepp J, Jabbour C, Behnes M, Becher T, Renker M, Lang S, Borggrefe M, Lehmann R, Akin I.
    Angiology; 2016 Mar 24; 67(3):272-80. PubMed ID: 26032849
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High osteoprotegerin levels predict MACCE in STEMI patients, but are not associated with myocardial salvage.
    Bjerre M, Munk K, Sloth AD, Nielsen SS, Flyvbjerg A, Bøtker HE.
    Scand Cardiovasc J; 2014 Aug 24; 48(4):209-15. PubMed ID: 24758546
    [Abstract] [Full Text] [Related]

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F, Susen S, Mouquet F, Pigny P, Cuilleret F, Sautière K, Collet JP, Beygui F, Hennache B, Ennezat PV, Juthier F, Richard F, Dallongeville J, Hillaert MA, Doevendans PA, Jude B, Bertrand M, Montalescot G, Van Belle E.
    Eur Heart J; 2012 Jan 13; 33(2):191-202. PubMed ID: 21719456
    [Abstract] [Full Text] [Related]

  • 14. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
    Meune C, Twerenbold R, Drexler B, Balmelli C, Wolf C, Haaf P, Reichlin T, Irfan A, Reiter M, Zellweger C, Meissner J, Stelzig C, Freese M, Capodarve I, Mueller C.
    Am J Cardiol; 2012 Apr 15; 109(8):1117-23. PubMed ID: 22257708
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D, Zhong W, Fan L, Chen L.
    Coron Artery Dis; 2012 Nov 15; 23(7):497-506. PubMed ID: 22968214
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.